UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000022570
Receipt number R000026015
Scientific Title Phase II trial of hypofractionated intensity modulated radiotherapy in patients with low risk prostate cancer
Date of disclosure of the study information 2016/06/01
Last modified on 2020/12/10 10:53:01

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Phase II trial of hypofractionated intensity modulated radiotherapy in patients with low risk prostate cancer

Acronym

HiMRT-P2

Scientific Title

Phase II trial of hypofractionated intensity modulated radiotherapy in patients with low risk prostate cancer

Scientific Title:Acronym

HiMRT-P2

Region

Japan


Condition

Condition

Prostate cancer

Classification by specialty

Urology Radiology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To examine the safety and efficacy of hypofractionated intensity modulated radiotherapy for localized prostate cancer

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Cumulative toxicity rate at 3 years after treatment

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Historical

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

radiotherapy

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male

Key inclusion criteria

pathological confirmation
<=T3bN0M0
age>=20 y.o.
PS=0 or 1
no history of pelvic irradiation
normal general condition
informed consent

Key exclusion criteria

no psychological disease
no long term steroid prescription
severe diabetes mellitus
no active infection

Target sample size

55


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Kasushige Hayakawa

Organization

Kitasato University school of medicine

Division name

department of radiology and radiation oncology

Zip code


Address

1-15-1 kitasato sagamiharashi-minamiku

TEL

042-778-8453

Email

hayakaz@med.kitasato-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name hiromichi ishiyama

Organization

kitasato university shool of medicine

Division name

department of radiology and radiation oncology

Zip code


Address

1-15-1 kitasato sagamiharashi-minamiku

TEL

042-778-8453

Homepage URL


Email

hishiyam@kitasato-u.ac.jp


Sponsor or person

Institute

Kitasato university

Institute

Department

Personal name



Funding Source

Organization

na

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2016 Year 06 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

55

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2015 Year 11 Month 25 Day

Date of IRB

2015 Year 11 Month 25 Day

Anticipated trial start date

2015 Year 11 Month 26 Day

Last follow-up date

2021 Year 02 Month 15 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2016 Year 06 Month 01 Day

Last modified on

2020 Year 12 Month 10 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000026015


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name